The More Life Company advances U.S. compounded pharmaceutical pathway for Quicksome™
The More Life Company Corp. signed a strategic letter of intent with a U.S. 503A compounding pharmacy to advance the development, compounding and commercialization of Quicksome™-enabled prescription compounded pharmaceutical products in the United States.